En Banc Rehearing Denied Over OxyContin Potency
A federal appeals court has denied a request for a panel or en banc rehearing of a qui tam suit alleging Purdue Pharma LP overstated the potency of its successful painkiller...To view the full article, register now.
Already a subscriber? Click here to view full article